SBC Medicals PE Ratio 2023-2024 | SBC
Current and historical p/e ratio for SBC Medicals (SBC) from 2023 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. SBC Medicals PE ratio as of September 25, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| SBC Medicals PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-09-26 | 9.28 | inf | |
| 2024-06-30 | 13.07 | 0 | 0.00 |
| 2024-03-31 | 12.70 | 0 | 0.00 |
| 2023-12-31 | 10.77 | 0 | 0.00 |
| 2023-09-30 | 10.68 | 0 | 0.00 |
| 2023-06-30 | 10.29 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.042B | $0.000B |
| SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $120.694B | 14.72 |
| Cencora (COR) | United States | $44.026B | 16.83 |
| ICON (ICLR) | Ireland | $23.422B | 21.05 |
| DiDi Global (DIDIY) | China | $21.386B | 0.00 |
| Avantor (AVTR) | United States | $17.452B | 26.46 |
| Natera (NTRA) | United States | $15.459B | 0.00 |
| Revvity (RVTY) | United States | $15.058B | 26.37 |
| Viatris (VTRS) | United States | $13.451B | 4.10 |
| CochLear (CHEOY) | Australia | $12.350B | 0.00 |
| Solventum (SOLV) | United States | $11.955B | 0.00 |
| Charles River Laboratories (CRL) | United States | $9.960B | 18.82 |
| Medpace Holdings (MEDP) | United States | $9.939B | 30.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.662B | 0.00 |
| Doximity (DOCS) | United States | $7.774B | 49.26 |
| HealthEquity (HQY) | United States | $6.773B | 36.76 |
| Bausch + Lomb (BLCO) | Canada | $6.696B | 28.82 |
| PACS (PACS) | United States | $6.076B | 0.00 |
| Life Times (LTH) | United States | $4.965B | 41.50 |
| Organon (OGN) | United States | $4.900B | 4.98 |
| Sotera Health (SHC) | United States | $4.699B | 23.70 |
| Surgery Partners (SGRY) | United States | $4.101B | 45.44 |
| Concentras Parent (CON) | United States | $2.912B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.761B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $2.565B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.539B | 95.57 |
| Alignment Healthcare (ALHC) | United States | $2.154B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.961B | 0.00 |
| Premier (PINC) | United States | $1.917B | 8.62 |
| AMN Healthcare Services Inc (AMN) | United States | $1.561B | 7.84 |
| CareDx (CDNA) | United States | $1.523B | 0.00 |
| Progyny (PGNY) | United States | $1.503B | 26.43 |
| Agilon Health (AGL) | United States | $1.498B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.450B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.123B | 29.39 |
| Establishment Labs Holdings (ESTA) | $1.115B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $0.992B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.902B | 9.82 |
| Embecta (EMBC) | United States | $0.838B | 5.58 |
| InnovAge Holding (INNV) | United States | $0.797B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.552B | 0.00 |
| Sharecare (SHCR) | United States | $0.528B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.467B | 0.00 |
| Enhabit (EHAB) | United States | $0.396B | 34.26 |
| Sonida Senior Living (SNDA) | United States | $0.382B | 0.00 |
| DocGo (DCGO) | United States | $0.343B | 12.89 |
| Sera Prognostics (SERA) | United States | $0.257B | 0.00 |
| Biodesix (BDSX) | United States | $0.247B | 0.00 |
| LifeMD (LFMD) | United States | $0.222B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.189B | 0.00 |
| ModivCare (MODV) | United States | $0.166B | 5.28 |
| Beauty Health (SKIN) | United States | $0.164B | 0.00 |
| MultiPlan (MPLN) | United States | $0.117B | 0.00 |
| Nutex Health (NUTX) | United States | $0.095B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.080B | 0.00 |
| So-Young (SY) | China | $0.075B | 18.16 |
| NeueHealth (NEUE) | United States | $0.041B | 1.65 |
| Singular Genomics Systems (OMIC) | United States | $0.039B | 0.00 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.019B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| KindlyMD (KDLY) | $0.007B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |